1. India Stocks

  2. •

    Retail trade

  3. •

    Drugstore chains
MedPlus Health Services Ltd.

MedPlus Health Services Ltd.

594.70
INR
-4.10
(-0.68%)
16.42EPS
49.29P/E
97.35BMarket Cap
Oct 27Next Earn
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
2026 Y
TTM
Revenue per Share
189.33
238.99
255.71
335.17
379.59
466.85
509.04
570.43
591.27
Basic EPS, GAAP
1
0.18
5.35
8.55
4.17
5.48
12.57
18.33
16.45
Free Cash Flow per Basic Share
10.47
-3.08
-4.31
4.66
-6.59
4.97
40.22
31.09
- -
Dividend per Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
Book Value per Share
24.42
44.24
61.23
118.84
125.23
132.13
145.48
164.61
- -
Tangible Book Value per Share
20.84
40.43
57.44
114.84
121.11
127.82
141.23
160.5
- -
Basic Weighted Avg Shares
119
119
119
112
119
119
120
120
120
Sales/Revenue/Turnover
22,589
28,513
30,508
37,554
45,287
55,735
60,875
68,353
70,927
Operating Margin (%)
2.75
3.22
4.22
4.17
1.93
2.36
4.19
5.01
4.22
Depreciation Expense
586
748
883
1,194
1,820
2,242
2,498
2,829
2,922
Net Income, GAAP
119
22
639
958
498
655
1,503
2,196
1,973
Effective Tax Rate (%)
47.6
93.89
33.64
19.69
- -
10.71
18.03
20.24
20.54
Profit Margin (%)
0.53
0.08
2.09
2.55
1.1
1.17
2.47
3.21
2.78
Working Capital
972
3,347
5,081
10,727
10,041
10,416
12,669
13,794
- -
LT Debt
2,840
3,193
4,001
5,965
8,012
8,681
10,080
12,331
- -
Total Equity
2,914
5,291
7,311
14,173
14,905
15,774
17,399
19,747
- -
Return on Invested Capital (%)
- -
0.65
7.48
7.25
- -
4.86
7.87
8.83
- -
Return on Capital (%)
- -
0.62
8.61
8.45
- -
6.09
8.61
10.09
- -
Return on Common Equity (%)
- -
0.53
10.15
8.92
3.42
4.27
9.06
11.82
- -

Capital Structure

INR

•

in mil. unless spec.
Dec'26
Mar'26
Jun'27
ST Debt
- -
1,913
- -
LT Borrowings
- -
- -
- -
LT Finance Leases
- -
12,331
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
120
120
120
Market Capitalization
96,731
100,791
97,355

Working Capital

INR

•

in mil. unless spec.
Dec'26
Mar'26
Jun'27
Total Current Assets
- -
20,687
- -
Cash, Cash Equivalents & STI
- -
5,925
- -
Accounts Receivable, Net
- -
230
- -
Inventories
- -
13,817
- -
Total Current Liabilities
- -
6,893
- -
Payables & Accruals
- -
- -
- -
ST Debt
- -
1,913
- -
Deferred Revenue
- -
- -
- -

Growth Rates

INR

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
25.73%
13.49%
Free Cash Flow
- -
12.06%
-22.54%
Net Income, GAAP
- -
41.85%
46.12%
Sales/Revenue/Turnover
- -
17.65%
12.29%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

INR

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
14,888
15,762
15,614
15,096
60,875
2026
15,426
- -
18,061
18,644
68,353
2027
18,796
- -
- -
- -
- -

Quarterly Earnings Per Share

INR

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
1.2
3.24
3.84
4.32
12.57
2026
3.54
- -
4.82
5.33
18.33
2027
2.76
- -
- -
- -
- -

Quarterly Dividends Per Share

INR

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -
2027
- -
- -
- -
- -
- -

Company Description

Company Profile APIChatGPT
CEO
Madhukar Reddy Gangadi
Full Time Employees
27,686
Sector
Retail trade
Industry
Drugstore chains
Address
Municipal No: 11-6-56 Hyderabad TS India 500037
IPO Date
Dec 23, 2021
Website
medplusindia.com
Similar Companies
CVS Health Corporation (NYSE:CVS)
MatsukiyoCocokara & Co. (TSE:3088)
Guardian Pharmacy Services, Inc. (NYSE:GRDN)
TSURUHA Holdings, Inc. (TSE:3391)
Raia Drogasil S.A. (B3:RADL3)
Sundrug Co., Ltd. (TSE:9989)
Business
MedPlus Health Services Limited (MEDPLUS.NS) operates as an integrated pharmacy retail chain in India, offering a comprehensive range of pharmaceutical and wellness products through its extensive network of stores and digital platforms. The company provides prescription and over-the-counter medicines, including generic and branded drugs; consumer health products such as vitamins, supplements, personal care items, and baby care essentials; beauty and cosmetics under its own brands like Sugar Cosmetics and NewU; and healthcare services including diagnostic tests, teleconsultations, and clinic operations. It also sells fast-moving consumer goods (FMCG), groceries, and ayurvedic products, primarily targeting individual consumers, households, and small clinics across urban, semi-urban, and rural markets in India. Founded in 2006 and headquartered in Hyderabad, Telangana, MedPlus conducts its operations nationwide with over 4,000 stores as of late 2025, supplemented by its online marketplace MedPlus Mart and a B2B distribution arm serving hospitals and pharmacies. The company serves as one of India's largest organized pharmacy retailers by store count and revenue, focusing on supply chain efficiency, private-label generics, and digital health integration to enhance accessibility in the retail pharmacy and healthcare services segments. In recent developments, MedPlus expanded its footprint through aggressive store additions, reaching approximately 4,150 outlets by Q2 FY2026, and strengthened its digital ecosystem with enhanced app features for home delivery and subscriptions. The company reported robust financial performance in FY2025, including revenue growth of over 20% year-over-year driven by omnichannel strategies, and launched new private-label offerings in nutraceuticals and dermatology categories. Additionally, it pursued strategic B2B growth via acquisitions of regional distributors and partnerships for diagnostic services, marking a shift toward integrated healthcare delivery amid India's expanding retail pharmacy market.